Theralase Technologies Inc. (TSXV:TLT)
Canada · Delayed Price · Currency is CAD 0.2850
+0.0300 (11.76%)
Apr 10, 2026, 3:59 PM EST
Theralase Technologies Market Cap
Theralase Technologies has a market cap or net worth of CAD 76.73 million as of April 10, 2026. Its market cap has increased by 62.31% in one year.
Market Cap
76.73M
Enterprise Value
76.97M
Revenue
1.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.29
Market Cap Chart
Since April 2, 1996, Theralase Technologies's market cap has increased from 8.33M to 76.73M, an increase of 821.41%. That is a compound annual growth rate of 7.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 76.73M | 75.55% |
| Dec 31, 2025 | 43.71M | -33.43% |
| Dec 31, 2024 | 65.66M | 64.23% |
| Dec 28, 2023 | 39.98M | -42.29% |
| Dec 30, 2022 | 69.28M | -9.56% |
| Dec 31, 2021 | 76.60M | 97.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Profound Medical | 329.55M |
| Cannabix Technologies | 89.49M |
| Perimeter Medical Imaging AI | 43.54M |
| Conavi Medical | 38.29M |
| Cheelcare | 32.61M |
| Aurora Spine | 21.30M |
| MedX Health | 19.68M |
| Ventripoint Diagnostics | 19.67M |